Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Target Validation, 2013
    Targeting the Voltage-Gated Proton Channel Hv1 for Neuroprotection

    Objective/Rationale:             
    The goal of this project is to validate the voltage-gated proton channel Hv1 as a target to reduce neuroinflammation and subsequent neurodegeneration in acute and...

  • Target Validation, 2013
    Bach1 and Bach2 Inhibit Nrf2 Antioxidant Responses in Substantia Nigra Neurons

    Objective/Rationale:             
    Oxidative stress and damage are well-known contributors in the pathogenesis of Parkinson’s disease (PD). To combat oxidative damage, transcription factor Nrf2...

  • Research Grant, 2013
    LRRK2 Effects on Neural Differentiation (Supplement 2)

    Promising Outcomes of Original Grant:
    Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) account for up to 13% of familial Parkinson's disease (PD) patients, but the function of LRRK2...

  • LRRK2 Challenge, 2013
    Impact of LRRK2 Kinase Activity on Synaptic Vesicle Trafficking 2013

    Objective/Rationale:
    Synapses provide a connection that allows signals to travel between neurons. Pre-clinical research showed that the LRRK2 kinase may influence synaptic function through effects on...

  • Biosample and Tissue Resource, 2013
    Discovery of Changes in N-linked Glycans Associated with Parkinson’s Disease

    Objective/Rationale:             
    The objective of this study is to explore the role of glycans (sugars attached to proteins) in the development and progression of Parkinson’s disease (PD). Glycans...

  • LRRK2 Challenge, 2013
    Investigation of LRRK2 as a Regulator of Microglial Cell Function

    Objective/Rationale:             
    Mutations of the LRRK2 gene are associated with Parkinson’s disease (PD), but very little is known about how or where the LRRK2 kinase normally functions in the brain...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.